Erratum: Methylation-specific digital karyotyping (Nature Protocols (2006) vol. 1 (1621-1636) 10.1038/nprot.2006.278);Methylation-specific digital karyotyping

Nature Protocols

Volumn 1, Issue 3, 2006, Pages 1621-1636

  Hu, Min ^a   Yao, Jun ^a   Polyak, Kornelia ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDODEOXYRIBONUCLEASE ASCI; ENDODEOXYRIBONUCLEASE NLAIII; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; DNA METHYLATION; GENE LIBRARY; GENETIC EPIGENESIS; GENOMICS; KARYOTYPING; METHODOLOGY;

DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA METHYLATION; EPIGENESIS, GENETIC; GENE LIBRARY; GENOMICS; KARYOTYPING;

EID: 34347217103     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2006.278     Document Type: Erratum

References (30)

1. Egger, G., Liang, G., Aparicio, A. & Jones, P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463 (2004).
2. De Smet, C., Lurquin, C., Lethe, B., Martelange, V. & Boon, T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327-7335 (1999).
3. Futscher, B.W. et al. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genet. 31, 175-179 (2002).
4. Takai, D. & Jones, P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 99, 3740-3745 (2002).
5. Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nature Genet 33 (Suppl): 245-254 (2003).
6. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
7. Ohlsson, R., Renkawitz, R. & Lobanenkov, V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. 17, 520-527 (2001).
8. Hark, A.T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405 486-489 (2000).
9. Bell, A.C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482-485 (2000).
10. Callinan, P.A. & Feinberg, A.P. The emerging science of epigenomics. Hum. Mol. Genet. 15 (Spec No 1): R95-R101 (2006).
11. Ushijima, T. Detection and interpretation of altered methylation patterns in cancer cells. Nature Rev. Cancer 5, 223-231 (2005)
12. Hayatsu, H., Wataya, Y., Kai, K. & Iida, S. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry 9 2858-2865 (1970).
13. Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genet. 37, 853-862 (2005).
14. Trinh, B.N., Long, T.I. & Laird, P.W. DNA methylation analysis by MethyLight technology. Methods 25, 456-462 (2001).
15. Gonzalgo, M.L. et al. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57 594-599 (1997).
16. Huang, T.H. et al. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res. 57, 1030-1034 (1997).
17. Ushijima, T. et al. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc. Natl. Acad. Sci. USA 94, 2284-2289 (1997).
18. Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307-2312 (1999).
19. Huang, T.H., Perry, M.R. & Laux, D.E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8, 459-470 (1999).
20. Shi, H. et al. Expressed CpG istand sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res. 62, 3214-3220 (2002).
21. Shi, H. et al. Triple analysis of the cancer epigenome: An integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res. 63, 2164-2171 (2003).
22. Ching, T.T. et al. Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nature Genet. 37, 645-651 (2005).
23. Yuan, E. et al. A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: Validation in decitabine therapy and tumor/ normal comparisons. Cancer Res. 66, 3443-3451 (2006).
24. Bathayer, K. et al. Genome-wide comparative isoschizomer profiling of cytosine methylation. Genome Res. (in the press).
25. Kawai, J. et al. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res. 21, 5604-5608 (1993).
26. Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H. & Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA 88, 9523-9527 (1991).
27. Hu, M. et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genet. 37, 899-905 (2005).
28. Wang, T.L. et al. Digital karyotyping. Proc. Natl. Acad. Sci. USA 99, 16156-16161 (2002).
29. Dai, Z. et al. An Asci boundary library for the studies of genetic and epigenetic alterations in CpG islands. Genome Res. 12, 1591-1598 (2002).
30. Cai, L. et al. Clustering analysis of SAGE data using a Poisson approach. Genome Biol. 5, R51 (2004).